Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Lasers Med Sci ; 39(1): 211, 2024 Aug 08.
Article in English | MEDLINE | ID: mdl-39115705

ABSTRACT

PURPOSE: To evaluate the effect of post-surgical photobiomodulation therapy in dogs. METHODS: Twenty dogs were selected for elective gastropexy and randomly divided into a control (CG, n = 10) and a PBMT group (PBMTG, n = 10). Pre­medication consisted of medetomidine and butorphanol. Meloxicam was administered before the procedure. Induction was performed with propofol and maintained with sevoflurane. Local blocks with lidocaine were used. Incisional gastropexy was performed in all animals. PBMTG received PBMT immediately after surgery. The need for postoperative rescue analgesia, if the animal had eaten by the evaluation momen, and pain scores were collected using the Glasgow Composite Measure Pain Scale - Short Form (CMPS­SF) at 1, 2, 4, 6, 8, 12, 16, 20, and 24 h post­endotracheal extubation. CMPS­SF scores were compared with the Mann-Whitney Test and proportions of animals that required rescue analgesia and had eaten with a χ2 test. P was set at < 0.05. RESULTS: No rescue analgesia was needed for any animal. Still, significant differences were observed in CMPS-SF scores between CG and PBMTG between 1 and 4 h post-extubation. PBMTG had a significantly higher proportion of animals eating up to the 8 h post-extubation evaluation moment. CONCLUSION: Adding post-surgical photobiomodulation to a standard anesthesia and analgesia protocol reduced CMPS-SF scores and increased the proportion of animals that resumed eating compared to the standard protocol alone.


Subject(s)
Gastric Dilatation , Gastropexy , Low-Level Light Therapy , Stomach Volvulus , Low-Level Light Therapy/veterinary , Gastropexy/veterinary , Animals , Dogs , Gastric Dilatation/surgery , Stomach Volvulus/surgery , Medetomidine/administration & dosage , Meloxicam/administration & dosage , Butorphanol/administration & dosage , Propofol/administration & dosage , Sevoflurane/administration & dosage , Treatment Outcome , Anesthesia , Analgesia , Pain Measurement/veterinary , Analgesics/administration & dosage
2.
J Am Vet Med Assoc ; 262(6): 1-5, 2024 Jun 01.
Article in English | MEDLINE | ID: mdl-38520751

ABSTRACT

OBJECTIVE: To evaluate the association of mesenteric volvulus (MV) in New York Police Department police working dogs (PWDs) with and without a prior prophylactic laparoscopic gastropexy (PLG). ANIMALS: 370 PWDs (82 with and 288 without PLG). METHODS: Medical records and surgery and radiology reports were reviewed from 2012 to 2022. Signalment, pertinent history (medical and surgical), gastropexy status, temperament, and training type were recorded. Statistical analysis was used to identify the relationship between prophylactic gastropexy and MV within the patient population. RESULTS: 3 cases of mesenteric volvulus were noted in this patient population. Two (2.4%) of the 82 PWDs that had undergone prophylactic laparoscopic gastropexy developed MV, whereas 1 (0.3%) of the 288 PWDs that had not undergone a gastropexy procedure developed MV. Police working dogs with PLG were estimated to be at 7.2 times greater odds of MV (point estimate OR, 7.18; 95% CI, 0.642 to 80.143); however, the low incidence of MV in this population limited statistical power, and thus this effect did not achieve statistical significance. Evaluation of MV incidence in additional populations of working dogs will allow greater precision in the point estimate. CLINICAL RELEVANCE: Prophylactic gastropexy may be associated with an increased risk for MV. However, patients without prophylactic gastropexy are at risk for gastric dilatation and volvulus, which is more common than MV. Therefore, the authors continue to recommend prophylactic gastropexy to decrease the risk for gastric dilatation and volvulus.


Subject(s)
Dog Diseases , Gastropexy , Laparoscopy , Animals , Dogs , Dog Diseases/surgery , Dog Diseases/prevention & control , Gastropexy/veterinary , Female , Male , Laparoscopy/veterinary , Working Dogs , New York/epidemiology , Retrospective Studies , Intestinal Volvulus/veterinary , Intestinal Volvulus/surgery , Intestinal Volvulus/prevention & control
3.
Vet Anaesth Analg ; 51(3): 235-243, 2024.
Article in English | MEDLINE | ID: mdl-38413340

ABSTRACT

OBJECTIVE: To investigate if preoperative ondansetron reduces postoperative nausea associated with laparoscopic gastropexy and castration in dogs. STUDY DESIGN: Prospective clinical study. ANIMALS: Twenty client-owned, healthy male dogs. METHODS: Dogs were premedicated with dexmedetomidine (2-5 mcg kg-1) and methadone (0.2-0.5 mg kg-1) intramuscularly. General anesthesia was induced with propofol and maintained with an inhalant anesthetic agent. Dogs were randomized into group S (saline 0.1 mL kg-1, intravenously) or group O (ondansetron 0.2 mg kg-1, intravenously). Plasma and serum were collected before premedication and 3 hours postextubation to measure arginine vasopressin (AVP) and cortisol concentrations. Nausea scoring occurred before and 10 minutes after premedication, immediately after extubation, and at 1, 2 and 3 hours postextubation. Data were analyzed by mixed and split-plot anova with Bonferroni adjustment for the number of group comparisons. Significance was set at p < 0.05. RESULTS: Nausea scores increased over time at 1 (p = 0.01) and 2 (p < 0.001) hours postextubation in both groups compared with before premedication. Median nausea score (0-100 mm) for groups S and O before premedication were 2.5 and 0.5 mm, respectively. At 1 and 2 hours postextubation, group S scored 7.5 and 4.0 mm and group O scored 6.0 and 5.0 mm, respectively. No significant differences in nausea scores within or between groups were observed before premedication and 3 hours postextubation. Cortisol concentrations increased significantly 3 hours postextubation in both groups (p < 0.001) compared with before premedication, with no differences between groups. AVP concentrations showed no significant differences within or between groups. CONCLUSIONS AND CLINICAL RELEVANCE: Preoperative intravenous administration of ondansetron (0.2 mg kg-1) did not impact postoperative nausea after laparoscopic gastropexy and castration. Investigation of higher doses of ondansetron on the incidence of postoperative nausea and vomiting in dogs after surgery is warranted.


Subject(s)
Antiemetics , Gastropexy , Laparoscopy , Ondansetron , Orchiectomy , Postoperative Nausea and Vomiting , Dogs , Animals , Male , Ondansetron/administration & dosage , Postoperative Nausea and Vomiting/veterinary , Postoperative Nausea and Vomiting/prevention & control , Laparoscopy/veterinary , Antiemetics/administration & dosage , Orchiectomy/veterinary , Orchiectomy/adverse effects , Gastropexy/veterinary , Dog Diseases/surgery , Prospective Studies , Preoperative Care/veterinary , Preoperative Care/methods
4.
Can Vet J ; 65(1): 33-36, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38164372

ABSTRACT

Bilious abdomen is an uncommon but life-threatening condition that has not previously been associated with prophylactic gastropexy. In animals, bilious abdomen is associated with a high mortality rate, due in large part to resulting bile peritonitis. Most bilious abdomen cases in veterinary medicine occur secondary to underlying gallbladder disease or blunt abdominal trauma. This case report describes an instance of atraumatic bilious abdomen with no evidence of primary hepatobiliary disease. Prophylactic incisional gastropexy was performed on a dog within 72 h of its developing bilious abdomen. It is possible that undergoing a gastropexy increased tension on the common bile duct, but no known direct surgical trauma to the duct occurred. The cause of bile leakage in this case is suspected to be secondary to trauma from a distended hollow viscus. Findings at the time of the second surgery support this conclusion. Key clinical message: This case suggests a novel mechanism for the development of bilious abdomen in dogs.


Développement d'un abdomen bilieux chez un chien après une gastropexie incisionnelle prophylactique et un événement de distension des viscères creux. L'abdomen bilieux est une affection rare mais potentiellement mortelle qui n'a jamais été associée à une gastropexie prophylactique. Chez les animaux, l'abdomen bilieux est associé à un taux de mortalité élevé, dû en grande partie à la péritonite biliaire qui en résulte. La plupart des cas d'abdomen bilieux en médecine vétérinaire sont secondaires à une maladie sous-jacente de la vésicule biliaire ou à un traumatisme contondant abdominal. Ce rapport de cas décrit un cas d'abdomen bilieux atraumatique sans signe de maladie hépatobiliaire primaire. Une gastropexie incisionnelle prophylactique a été réalisée sur un chien dans les 72 heures précédant le développement de son abdomen bilieux. Il est possible que la gastropexie ait augmenté la tension sur le canal biliaire principal, mais aucun traumatisme chirurgical direct connu du canal ne s'est produit. La cause de la fuite biliaire dans ce cas est soupçonnée d'être secondaire à un traumatisme causé par un viscère creux distendu. Les résultats de la deuxième intervention chirurgicale confortent cette conclusion.Message clinique clé :Ce cas suggère un nouveau mécanisme pour le développement de l'abdomen bilieux chez le chien.(Traduit par Dr Serge Messier).


Subject(s)
Dog Diseases , Gastropexy , Stomach Volvulus , Dogs , Animals , Stomach Volvulus/veterinary , Gastropexy/veterinary , Gastropexy/methods , Dog Diseases/surgery , Abdomen , Common Bile Duct
SELECTION OF CITATIONS
SEARCH DETAIL